Long-term outcomes of premature acute myocardial infarction: impact of multivessel disease

Sang Hyun Kim(St. Mary's Hospital), Kiyuk Chang, Ki‐Dong Yoo(The Catholic University of Korea St. Vincent's Hospital), Byung‐Hee Hwang(The Catholic University of Korea Seoul St. Mary's Hospital), Mahn-won Park(The Catholic University of Korea Daejeon St. Mary's Hospital), Eun Ho Choo(St. Mary's Hospital), Min Chul Kim(Chonnam National University), Kwan Yong Lee(St. Mary's Hospital), Youngkeun Ahn(Chonnam National University), Wonjae Lee(St. Mary's Hospital), Chul Soo Park(The Catholic University of Korea Yeouido St. Mary's Hospital), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Ik Jun Choi(The Catholic University of Korea Incheon St. Mary's Hospital), J. H. LEE(The Catholic University of Korea Uijeongbu St. Mary's Hospital)
Coronary Artery Disease
January 20, 2026
10.1097/mca.0000000000001613
Cited by 0

Related Papers

Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304
Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial
|The Lancet|2021|202
Effect of Coronary CTA on Chronic Total Occlusion Percutaneous Coronary Intervention
|JACC. Cardiovascular imaging|2021|98
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial
|The Lancet|2025|86
Benefit of β-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention
|Heart|2014|79